Sensorion SA (ALSEN.PA)

EUR 0.64

(-6.16%)

Net Income Summary of Sensorion SA

  • Sensorion SA's latest annual net income in 2023 was -22.06 Million EUR , up 4.94% from previous year.
  • Sensorion SA's latest quarterly net income in 2024 Q2 was -13.89 Million EUR , down 0.0% from previous quarter.
  • Sensorion SA reported an annual net income of -23.2 Million EUR in 2022, down -53.33% from previous year.
  • Sensorion SA reported an annual net income of -15.13 Million EUR in 2021, down -68.6% from previous year.
  • Sensorion SA reported a quarterly net income of -12.28 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Sensorion SA reported a quarterly net income of -9.77 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Sensorion SA (2023 - 2011)

Historical Annual Net Income of Sensorion SA (2023 - 2011)

Year Net Income Net Income Growth
2023 -22.06 Million EUR 4.94%
2022 -23.2 Million EUR -53.33%
2021 -15.13 Million EUR -68.6%
2020 -8.97 Million EUR 25.78%
2019 -12.09 Million EUR 2.06%
2018 -12.35 Million EUR -27.5%
2017 -9.68 Million EUR -30.67%
2016 -7.41 Million EUR -73.56%
2015 -4.27 Million EUR -38.62%
2014 -3.08 Million EUR -87.09%
2013 -1.64 Million EUR -66.79%
2012 -987.33 Thousand EUR -102.67%
2011 -487.16 Thousand EUR 0.0%

Peer Net Income Comparison of Sensorion SA

Name Net Income Net Income Difference
ABIONYX Pharma SA -3.51 Million EUR -527.158%
ABIVAX Société Anonyme -147.74 Million EUR 85.066%
Adocia SA -21.16 Million EUR -4.26%
Aelis Farma SA -5.07 Million EUR -334.49%
Biophytis S.A. -17.02 Million EUR -29.587%
Advicenne S.A. -7.03 Million EUR -213.802%
genOway Société anonyme 1.56 Million EUR 1507.486%
IntegraGen SA -171.39 Thousand EUR -12772.54%
Medesis Pharma S.A. -3.95 Million EUR -457.228%
Neovacs S.A. -8.74 Million EUR -152.342%
NFL Biosciences SA -3.74 Million EUR -489.068%
Plant Advanced Technologies SA 79.16 Thousand EUR 27968.742%
Quantum Genomics Société Anonyme -3.17 Million EUR -595.799%
Theranexus Société Anonyme -6.82 Million EUR -223.134%
TME Pharma N.V. -6.73 Million EUR -227.545%
Valbiotis SA -7.36 Million EUR -199.449%
TheraVet SA -1.57 Million EUR -1304.68%
Valerio Therapeutics Société anonyme -20.34 Million EUR -8.452%
argenx SE -272.91 Million EUR 91.916%
BioSenic S.A. -28.77 Million EUR 23.332%
Celyad Oncology SA -8.44 Million EUR -161.167%
DBV Technologies S.A. -67.26 Million EUR 67.201%
Galapagos NV 211.69 Million EUR 110.422%
Genfit S.A. -28.89 Million EUR 23.64%
GeNeuro SA -14.75 Million EUR -49.511%
Hyloris Pharmaceuticals SA -15.38 Million EUR -43.455%
Innate Pharma S.A. -7.57 Million EUR -191.458%
Inventiva S.A. -110.42 Million EUR 80.02%
MaaT Pharma SA -19.71 Million EUR -11.9%
MedinCell S.A. -25.03 Million EUR 11.88%
Nanobiotix S.A. -39.7 Million EUR 44.425%
Onward Medical N.V. -36.18 Million EUR 39.019%
Oryzon Genomics S.A. -3.35 Million EUR -558.031%
OSE Immunotherapeutics SA -23 Million EUR 4.085%
Oxurion NV -18.96 Million EUR -16.313%
Pharming Group N.V. -9.75 Million EUR -126.139%
Poxel S.A. -35.09 Million EUR 37.123%
GenSight Biologics S.A. -26.22 Million EUR 15.853%
Transgene SA -22.32 Million EUR 1.185%
Financière de Tubize SA 88.15 Million EUR 125.029%
UCB SA 343 Million EUR 106.432%
Valneva SE -101.42 Million EUR 78.247%
Vivoryon Therapeutics N.V. -28.34 Million EUR 22.153%